Thrombolysis for acute stroke

Progress in Cardiovascular Diseases

Volumn 42, Issue 3, 1999, Pages 175-183

  Lyden, P D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOLYTIC AGENT; STREPTOKINASE; UROKINASE;

BLOOD CLOT LYSIS; BRAIN ISCHEMIA; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; PRACTICE GUIDELINE; RECANALIZATION; REVIEW; RISK BENEFIT ANALYSIS; STROKE;

EID: 0032709964     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-0620(99)70001-0     Document Type: Article

References (64)

1. G del Zoppo Thrombolytic therapy in cerebrovascular disease Curr Concept Cerebrovasc Dis 23 1988 7 12
2. E Mori Y Yoneda M Tabuchi Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke Neurology 42 1992 976 982
3. AP Fletcher N Alkjaersig M Lewis A pilot study of urokinase therapy in cerebral infarction Stroke 7 1976 135 142
4. J Hanaway R Torack AP Fletcher Intracranial bleeding associated with urokinase therapy for acute ischemic hemispheral stroke Stroke 7 1976 143 146
5. JS Meyer J Gilroy ME Barnhart JF Johnson Therapeutic thrombolysis in cerebral thromboembolism: Randomized evaluation of intravenous streptokinase, in Cerebral Vascular Diseases, Fourth Princeton Conference CH Millikan RG Siekert JP Whisnant 1965 Grune and Stratton New York 200 213
6. G del Zoppo BR Copeland TA Waltz The beneficial effect of intracarotid urokinase on acute stroke in a baboon model Stroke 17 1986 638 643
7. JA Zivin M Fisher U DeGirolami Tissue plasminogen activator reduces neurological damage after cerebral embolism Science 230 1985 1289 1292
8. WM Clark KP Madden PD Lyden Cerebral hemorrhagic risk of aspirin or heparin therapy with thrombolytic treatment in rabbits Stroke 22 1991 872 876
9. PD Lyden JA Zivin WA Clark Tissue plasminogen activator mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits Neurology 39 1989 703 708
10. BB Chehrazi JA Seibert P Kissel Evaluation of recombinant tissue plasminogen activator in embolic stroke Neurosurgery 24 1989 355 360
11. PD Lyden KP Madden WM Clark Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits Stroke 21 1990 1589 1593
12. K Overgaard T Sereghy G Boysen Reduction of infarct volume and mortality by thrombolysis in a rat embolic stroke model Stroke 23 1992 1167 1174
13. DA Phillips MA Davis M Fisher Selective embolization and clot dissolution with rt-PA in the internal carotid artery circulation of the rabbit Am J Neuroradiol 9 1988 899 902
14. BD Watson R Prado WD Dietrich Mitigation of evolving cortical infarction in rats by recombinant tissue plasminogen activator following photochemically induced thrombosis, in Cerebrovascular Diseases: Fifteenth Research (Princeton) Conference WJ Powers ME Raichle 1987 Raven Press New York 317 330
15. MP Bowes JA Zivin GR Thomas Acute hypertension, but not thrombolysis, increases the incidence and severity of hemorrhagic transformation following experimental stroke in rabbits Exp Neurol 141 1996 40 46
16. JA Zivin V Mazzarella Tissue plasminogen activator plus glutamate antagonist improves outcome after embolic stroke Arch Neurol 48 1991 1235 1238
17. RL Zhang ZG Zhang M Chopp Increased therapeutic efficacy with rrt-PA and anti-CD18 antibody treatment of stroke in the rat Neurology 52 1999 273 279
18. G del Zoppo A Ferber S Otis Local intra-arterial fibrinolytic therapy in acute cartoid territory stroke Stroke 19 1988 307 313
19. E Mori M Tabuchi T Yoshida Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery Stroke 19 1988 802 812
20. W Hacke H Zeumer A Ferbert Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease Stroke 19 1988 1216 1222
21. EB Ringelstein R Biniek C Weiller Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization Neurology 42 1992 289 298
22. R von Kummer W Hacke Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke Stroke 23 1992 646 652
23. TG Brott EC Haley Jr DE Levy Urgent therapy for stroke: Part 1. Pilot study of tissue plasminogen activator administered within 90 minutes Stroke 23 1992 632 640
24. EC Haley Jr DE Levy TG Brott Urgent therapy for stroke. Part II. Pilot study of tissue plasminogen activator administered 91-180 minutes from onset Stroke 23 1992 641 645
25. G del Zoppo K Poeck MS Pessin Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke Ann Neurol 32 1992 78 86
26. EC Haley TG Brott GL Sheppard Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke Stroke 24 1993 1000 1004
27. W Hacke M Kaste C Fieschi Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Stroke Study (ECASS) JAMA 274 1995 1017 1025
28. NINDS rrt-PA Stroke Study Group: Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1587
29. TPA NINDS Stroke Study Group Generalized Efficacy of rt-PA for Acute Stroke Stroke 28 1997 2119 2125
30. TPA NINDS Stroke Study Group Intracerebral Hemorrhage After Intravenous t-Pa Therapy for Ischemic Stroke Stroke 28 1997 2109 2118
31. W Hacke E Bluhmki T Steiner Dichotomized Efficacy End Points and Global End-Point Analysis Applied to the ECASS Intention-to-Treat Data Set Stroke 29 1998 2073 2075
32. T Steiner E Bluhmki M Kaste The ECASS 3-Hour Cohort Cerebrovasc Dis 8 1998 198 203
33. W Hacke M Kaste C Fieschi Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) Lancet 352 1998 1245 1251
34. WM Clark GW Albers The ATLANTIS Stroke Study Investigators The Atlantis rrt-PA (alteplase) acute stroke trial: Final results Stroke 30 1999 234 (abstr)
35. GA Donnan SM Davis BR Chambers Trials of streptokinase in severe acute ischaemic stroke Lancet 345 1995 578 579
36. M Hommel JP Boissel C Cornu Termination of streptokinase in severe acute ischaemic stroke Lancet 345 1995 57
37. Multicenter Acute Stroke Trial—Europe (MAST-E) Results of safety and efficacy MAST-E investigators group Cerebrovasc Dis 5 1995 225 273 (abstr)
38. Multicentre Acute Stroke Trial-Italy (MAST-I) Group Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke Lancet 346 1995 1509 1514
39. GA Donnan SM Davis BR Chambers ASK Trial: Unfavourable outcome if treated more than three hours after onset Cerebrovasc Dis 5 1995 225 273 (abstr)
40. SC Fagan LB Morgenstern A Petitta Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke Neurology 50 1998 883 890
41. S Avruch AP Cackley Savings achieved by giving WIC benefits to women prenatally Public Health Rep 110 1995 27 34
42. SC Schoenbaum JN Hyde L Baroshesky Benefit-cost analysis of rubella vaccination policy N Engl J Med 294 1976 306 310
43. JP Koplan SC Schoenbaum MC Weinstein Pertussis vaccine—an analysis of benefits, risks and costs N Engl J Med 301 1979 906 911
44. JP Koplan SR Preblud A benefit-cost analysis of mumps vaccine Am J Dis Child 136 1982 362 364
45. WA Cutting Cost-benefit evaluations of vaccination programmes Lancet pt 1 1980 634 635 8195
46. A Furlan G Kanoti When is thrombolysis justified in patients with acute ischemic stroke? A bioethical perspective Stroke 1997 214 218
47. G: del Zoppo Acute stroke: On the threshold of a therapy? New Engl J Med 333 1995 1632 1633
48. L Caplan JP Mohr JP Kistler Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? Thrombolysis—not a panacea for ischemic stroke New Engl J Med 337 1997 1309 1310
49. D Chiu D Krieger C Villar-Cordova Intravenous tissue plasminogen activator for acute ischemic stroke feasibility, safety, and efficacy in the first year of clinical practice Stroke 29 1998 18 22
50. M Grond J Rudolf S Schmulling Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke Arch Neurol 55 1998 466 469
51. D Tanne H Mansbach P Verro Intravenous rrt-PA therapy for stroke in clinical practice: A multicenter evaluation of outcome Stroke 29 1998 288
52. D Tanne P Verro H Mansbach Overview and summary of phase IV data on use of rt-PA for acute ischemic stroke Stroke Interventionalist 1 1998 3 5
53. TG Kwiatkowski RB Libman M Frankel The NINDS rrt-PA stroke study group: Effects of tissue plasminogen activator for acute ischemic stroke at one year N Engl J Med 340 1989 1781 1787
54. G del Zoppo RT Higashida AJ Furlan PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke Stroke 29 1998 4 11
55. AJ Furlan RT Higashida L Wechsler PROACT II: Recombinant prourokinase (r-ProUK) in acute cerebral thromboembolism. Initial trial results Stroke 30 1999 234 (abstr)
56. HP Adams Jr TG Brott AJ Furlan Guidelines for thrombolytic therapy for acute stroke: A supplement to the guidelines for the management of patients with acute ischemic stroke Circulation 94 1996 1167 1174
57. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Thrombolytic therapy for acute ischemic stroke—Summary Statement Neurology 47 1996 835 839
58. P Bratina L Greenberg W Pasteur Current emergency department management of stroke in Houston, Texas Stroke 26 1995 409 414
59. PD Lyden K Rapp T Babcock Ultra-rapid identification, triage, and enrollment of stroke patients into clinical trials J Stroke Cerebrovasc Dis 4 1994 106 113
60. BC Tilley PD Lyden TG Brott Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke Arch Neurol 54 1997 1466 1474
61. MA Albanese WR Clarke HP Adams Jr Ensuring reliability of outcome measures on multicenter clinical trials of treatments for acute ischemic stroke: The program developed for the trial of ORG 10172 in acute stroke treatment (TOAST) Stroke 25 1994 1746 1751
62. P Lyden T Brott B Tilley Improved reliability of the NIH stroke scale using video training Stroke 25 1994 2220 2226
63. PD Lyden L Hantson Assessment scales for the evaluation of stroke patients J Stroke Cerebrovasc Dis 7 1998 113 127
64. SC Fagan MP Bowes PD Lyden JA Zivin Acute hypertension promotes hemorrhagic transformation in a rabbit embolic stroke model: Effect of labetalol Exp Neurol 150 1998 153 158